Your session is about to expire
← Back to Search
Enzalutamide + Paclitaxel for Breast Cancer
Study Summary
This trial is studying a combination of drugs given before surgery to see how well it works in treating patients with triple-negative breast cancer.
- Stage III Breast Cancer
- Breast Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a condition in your digestive system that could make it hard for your body to absorb enzalutamide. Or, you have had colitis in the past.You have had a severe allergic reaction to paclitaxel, even with the use of pre-medication.You need to take corticosteroids every day, except for when you're given them before anthracycline-based chemotherapy.You have not had any other cancer treatments, except for a specific type of chemotherapy called anthracycline-based neoadjuvant chemotherapy for your current cancer.You have a history of seizures or conditions that make you more likely to have seizures, like a stroke or severe head injury. You also had a loss of consciousness or a mini-stroke within the past year.You have cancer that has spread to your brain or the membranes surrounding your brain.
- Group 1: Treatment (enzalutamide, paclitaxel)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people are participating in this clinical trial?
"That is correct. The information available on clinicaltrials.gov supports that this trial is ongoing and seeking new participants. According to the site, the study was established on September 22nd, 2016 and was updated on September 22nd, 2020. They are looking for a total of 37 patients from 2 different locations."
Is recruitment still underway for this research project?
"The listing on clinicaltrials.gov shows that this study is still looking for patients to enroll. The trial was originally posted on September 22nd, 2016 and has since been updated multiple times, with the most recent edit being on September 22nd, 2020. Currently, 37 people are needed between 2 different sites."
Are there other ongoing research studies that focus on Axillary Lymph Node Dissection?
"At present, there are 973 clinical trials studying axillary lymph node dissection (ALND), with 264 of those trials in Phase 3. Most of the ALND clinical trials are located in Germantown, Tennessee, but there are 51812 locations worldwide conducting studies on this topic."
What is the standard medical procedure for Axillary Lymph Node Dissection?
"Axillary Lymph Node Dissection is a viable treatment option for patients struggling with neoplasm metastasis, kaposi sarcoma, and advance directives."
What is the most common side effect for patients who undergo Axillary Lymph Node Dissection?
"Phase 2 trials are limited to safety data, so our team has given Axillary Lymph Node Dissection a score of 2."
Share this study with friends
Copy Link
Messenger